Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PC INTERACTOME

Financiado

Cerrado

Assembly of a prostate cancer genome wide molecular interactome for the identifi...

Assembly of a prostate cancer genome wide molecular interactome for the identification of the key regulatory genes of malignant transformation and new targets for therapeutic intervention A major issue in the translation of findings from mouse models to clinical practice is the lack of appropriate tools to identify causal mechanisms of oncogenesis, tumor progression, and drug activity. The multidisciplinary project... ver más

14/08/2013

FUNDACIO INSTITUT...

242K€

Presupuesto del proyecto: 242K€

Líder del proyecto

FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 16M€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-08-14 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

FUNDACIO INSTITUT D?INVESTIG...

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PPI-MARKER Interruption of protein protein interaction and network to c... 173K€ Cerrado

ONCOPROTNET Dynamic protein interaction networks in cancer 100K€ Cerrado

RTI2018-097267-B-I00 ANALISIS BIOINFORMATICO INTEGRAL DEL SECRETOMA HUMANO Y SU I... 133K€ Cerrado

BIO2014-57291-R NUEVAS ESTRATEGIAS PARA EL DESCUBRIMIENTO DE DIANAS MOLECULA... 303K€ Cerrado

SAF2014-60507-JIN IDENTIFICACION DE DETERMINANTES MOLECULARES Y NUEVAS DIANAS... 206K€ Cerrado

MYCNEXT Connecting the activities of c Myc in genome regulation cel... 2M€ Cerrado

Líder del proyecto

FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5 | 16M€

Presupuesto del proyecto 242K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto A major issue in the translation of findings from mouse models to clinical practice is the lack of appropriate tools to identify causal mechanisms of oncogenesis, tumor progression, and drug activity. The multidisciplinary project here proposed will characterize fundamental mechanisms and signaling pathways deregulated in prostate cancer through the assembly of a prostate cancer interactome, which is an accurate network of transcriptional and post-translational molecular interactions. Importantly, we will utilize reverse-engineering approaches that are unbiased and encompass the entire genome. We will use gene expression profiling of samples from different mouse models in order to have a representation of all the stages of the disease. This novel mouse to human paradigm will allow distinguishing the drivers of prostate cancer from the large number of passenger genes whose expression is coincidentally rather than causally altered in cancer progression. Key regulators will then be validated by expression analyses in mouse and human prostate cancers tissue micro-arrays to assess their relationship to disease aggressiveness and outcome. Finally, interrogation of this interactome will allow the identification of novel druggable targets for prostate cancer therapy. Candidate targets will be identified focusing first on those genes that can modulate particular signaling pathways deregulated in prostate cancer, and second on candidate targets that may induce tumor-cell specific apoptosis. Next, we will validate the expression of these candidate targets in human prostate cancer specimens, thus allowing the identification of the individuals that might benefit from specific interventions. The integrated in vivo modeling and bioinformatics study on prostate cancer proposed here will improve the capacity of the European host institution of conducting cutting edge research on this area and should constitute a significant step forward in the European leadership in the field.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores